Belgian biotech Agomab…
Belgian biotech Agomab Therapeutics and eye-focused drug delivery company SpyGlass [...]
As Priovant works toward approval…
As Priovant works toward approval of potential blockbuster brepocitinib as [...]
Angitia Biopharmaceuticals has…
Angitia Biopharmaceuticals has unveiled its second mega-round in 14 months, [...]
Clinical-stage antibody company…
Clinical-stage antibody company Generate:Biomedicines is the latest biotech to mull [...]
Quell Therapeutics is pressing…
Quell Therapeutics is pressing pause on an engineered regulatory T-cell [...]
Bayer has linked asundexian to a…
Bayer has linked asundexian to a 26% reduction in stroke [...]
Eikon Therapeutics is heading to…
Eikon Therapeutics is heading to the Nasdaq this morning with [...]
As Eli Lilly awaits an FDA…
As Eli Lilly awaits an FDA approval decision for its [...]
Novartis has nixed six early-stage…
Novartis has nixed six early-stage pipeline programs, swapping in two [...]
Stem cell therapy biotech PrimeGen…
Stem cell therapy biotech PrimeGen US is taking the less-traveled [...]